THE USE OF CLOZAPINE AMONG INDIVIDUALS WITH INTELLECTUAL DISABILITY: A REVIEW
Spremljeno u:
SINGH, A.N., ET AL., THE USE OF CLOZAPINE AMONG INDIVIDUALS WITH INTELLECTUAL DISABILITY: A REVIEW. Research in Developmental Disabilities, Vol. 31, no. 6 (2010), p. 1135-1141.
Ref.
171312
Lokacija:
SIIS R.775 Archivo
Palabras clave:
Discapacidad intelectual, Efectos, Evaluación de servicios, Fármacos, Literatura científica, Trastornos de la conducta, Tratamiento médico
Discapacidad intelectual, Efectos, Evaluación de servicios, Fármacos, Literatura científica, Trastornos de la conducta, Tratamiento médico
Slični predmeti: THE USE OF CLOZAPINE AMONG INDIVIDUALS WITH INTELLECTUAL DISABILITY: A REVIEW
- GUIDELINES FOR THE USE OF CLOZAPINE IN INDIVIDUALS WITH DEVELOPMENTAL DISABILITIES
- PRACTICAL GUIDELINES FOR THE USE OF NEW GENERATION ANTIPSYCHOTIC DRUGS (EXCEPT CLOZAPINE) IN ADULT INDIVIDUALS WITH INTELLECTUAL DISABILITIES
- THE USE OF RISPERIDONE AMONG INDIVIDUALS WITH MENTAL RETARDATION: CLINICALLY SUPPORTED OR NOT?
- EFFECTS OF CLOZAPINE ON SELF-INJURIOUS BEHAVIOR OF TWO RISPERIDONE NONRESPONDERS WITH MENTAL RETARDATION
- THE EFFECT OF CLOZAPINE ON SELF-INJURIOUS BEHAVIOR
- THE USE OF PSYCHOTROPIC MEDICATION FOR THE MANAGEMENT OF PROBLEM BEHAVIOURS IN ADULTS WITH INTELLECTUAL DISABILITIES LIVING IN CANADA